NPI: 1619567625 · MINNEAPOLIS, MN 55415 · Mail Order Pharmacy · NPI assigned 01/23/2021
| Authorized Official | ANDERSON, LISA (CFO) |
| NPI Enumeration Date | 01/23/2021 |
Other providers sharing the same authorized official: ANDERSON, LISA
| Provider | City | State | Total Paid |
|---|---|---|---|
| HENNEPIN HEALTHCARE SYSTEM, INC | MINNEAPOLIS | MN | $708.86M |
| HENNEPIN HEALTHCARE SYSTEM, INC | MINNEAPOLIS | MN | $23.17M |
| HENNEPIN HEALTHCARE SYSTEM, INC | MINNEAPOLIS | MN | $12.40M |
| HENNEPIN HEALTHCARE SYSTEM, INC | MINNEAPOLIS | MN | $638K |
| HENNEPIN HEALTHCARE SYSTEM INC | MINNEAPOLIS | MN | $294K |
| BEYOND WELLNESS PLLC | BOISE | ID | $234K |
| HENNEPIN HEALTHCARE SYSTEM, INC | MINNEAPOLIS | MN | $958.39 |
| ETS CONSULTING LLC | MOUNTLAKE TERRACE | WA | $0.00 |
| Year | Claims | Total Paid |
|---|---|---|
| 2022 | 1,820 | $6K |
| 2023 | 2,540 | $8K |
| 2024 | 1,949 | $6K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| J7507 | Tacrolimus, immediate release, oral, 1 mg | 777 | 703 | $7K |
| Q0512 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period | 2,236 | 1,106 | $6K |
| Q0511 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period | 1,125 | 1,065 | $5K |
| J7517 | Mycophenolate mofetil, oral, 250 mg | 1,064 | 953 | $3K |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 1,107 | 1,052 | $236.02 |